Vitamin D and Lung Cancer

Author(s): Helga Rhein

Journal Name: Current Respiratory Medicine Reviews

Volume 7 , Issue 6 , 2011

Become EABM
Become Reviewer
Call for Editor


Lung cancer is one of the most common cancers but treatment has limited success and survival rates remain low. The active metabolite of vitamin D, 1,25-dihydroxyvitamin D, has anti-proliferative and pro-apoptotic actions in lung carcinoma cell lines in vitro. Vitamin D deficiency is associated with poor prognosis in lung cancer, and lung cancer survival varies according to vitamin D receptor genotype. Randomized controlled trials should be performed to determine whether vitamin D supplementation might have a role as an adjunct to conventional treatments for lung cancer.

Keywords: Vitamin D, lung cancer, incidence, mortality, chemotherapy, radiotherapy, NSCLC, anti-angiogenic, pro-apoptotic, vitamin D supplementation

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Published on: 01 March, 2012
Page: [440 - 443]
Pages: 4
DOI: 10.2174/157339811798072649
Price: $65

Article Metrics

PDF: 15